Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
DXCM.MX
Strong BuyDexCom, Inc. · Healthcare · United States · $34.0B · Avg Vol: $44K/d
98
StockRankGet insider-trade alerts
Q
83
V
43
M
85
P/E (TTM)
35.7x
ROE
38.5%
D/E
0.5x
Dividend %
—
Loading 1Y...
PRICE (1Y)+12.6%
SMA 50SMA 200
Close
$89.79
RSI (14)
62.3
52W High
$91.43
From 52W High
1.0%
SCORE BREAKDOWN
Quality
83
ROIC
30.9%96.8
ROE
38.5%96.4
GP/Assets
49.0%86.1
Op. Margin
24.3%86.6
FCF/Assets
22.2%96.7
Piotroski
497.6
Int. Cover
50.0x89.3
D/E Ratio
0.53x28.8
Current Ratio
1.73x33.2
Value
43
P/E (TTM)
35.7x31.6
EV/EBITDA
24.3x25.3
P/FCF
24.2x53.3
P/B
0.8x90.8
P/S
6.9x34.5
Div Yield
—N/A
Momentum
85
52W High %
98%97.9
RS 6M
31%85.6
SMA 50/200
1.10x77.6
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
39%69.2
FUNDAMENTALS
Market Cap
$34.0B
P/E (Forward)
—
Gross Margin
62.5%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of DXCM.MX are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| DXCM.MX | DexCom, Inc.(you) | $34.0B | 98 | Strong Buy |
| ZBH | Zimmer Biomet Holdings, Inc. | $19.3B | 85 | Strong Buy |
| GMED | Globus Medical, Inc. | $11.3B | 92 | Strong Buy |
| STE | STERIS plc | $23.2B | 75 | Buy |
| GEHC | GE HealthCare Technologies Inc. | $33.5B | 65 | Hold |
| EW | Edwards Lifesciences Corporation | $52.2B | 67 | Buy |
| SYK.MX | Stryker Corporation | $130.8B | 83 | Strong Buy |
| BIO-B | Bio-Rad Laboratories, Inc. | $8.3B | 79 | Buy |
| HAE | Haemonetics Corporation | $4.9B | 86 | Strong Buy |
| BSX.MX | Boston Scientific Corporation | $70.7B | 60 | Hold |
Peer medians: ROE -25.9% · P/E 29.2x · Gross margin 58.7%